Shandong Sanyuan Biotechnology Co., Ltd
Online roadshow announcement of initial public offering and listing on GEM
Sponsor (lead underwriter): China Securities Co.Ltd(601066)
The application of Shandong Sanyuan Biotechnology Co., Ltd. (hereinafter referred to as the “issuer”) for initial public offering of no more than 33721000 common shares (A shares) and listing on the gem (hereinafter referred to as the “issuance”) has been examined and approved by the members of the GEM Listing Committee of Shenzhen Stock Exchange (hereinafter referred to as the “Shenzhen Stock Exchange”), It has been approved for registration by China Securities Regulatory Commission (zjxk [2021] No. 4073). The sponsor (lead underwriter) of this offering is China Securities Co.Ltd(601066) (hereinafter referred to as “sponsor (lead underwriter)”). The issuance adopts directional placement to strategic investors (hereinafter referred to as “strategic placement”) (if any) Offline inquiry and placement to qualified investors (hereinafter referred to as “offline issuance”) and online pricing issuance to social public investors holding non restricted A-Shares and non restricted depositary receipts in Shenzhen market (hereinafter referred to as “online issuance”).
This offering does not arrange strategic placement to other external investors. For example, the offering price exceeds the median and weighted average of offline investors’ quotation after excluding the highest quotation, as well as the Securities Investment Fund (hereinafter referred to as “public fund”) and the National Social Security Fund (hereinafter referred to as “social security fund”) established through public offering after excluding the highest quotation The lower of the median and weighted average of the quoted prices of the basic endowment insurance fund (hereinafter referred to as “pension”), the enterprise annuity fund established in accordance with the measures for the administration of enterprise annuity fund (hereinafter referred to as “enterprise annuity fund”) and the insurance fund (hereinafter referred to as “insurance fund”) in accordance with the measures for the administration of the use of insurance funds, The relevant subsidiaries of the sponsor will participate in the strategic placement of the offering in accordance with relevant regulations. The issuer and the (sponsor) lead underwriter of the offering will disclose the total amount of shares placed, the number of shares subscribed and the number of shares sold to the relevant subsidiaries of the sponsor participating in the placement in the announcement on the initial public offering of shares by Shandong Sanyuan Biotechnology Co., Ltd. and listing on the gem Information such as the proportion in the number of shares issued this time and the holding period.
The issuer and the recommendation institution (lead underwriter) will directly determine the issuance price through offline preliminary inquiry, and offline cumulative bidding inquiry will not be conducted. The number of shares in this public offering is 33721000, accounting for 25.00% of the total share capital after the issuance. This issue is a public offering of new shares without the transfer of old shares. After this public offering, the total share capital is 134883800 shares. Among them, Initial strategic placement (if the issue price exceeds the lower of the median and weighted average of offline investors’ quotations after excluding the highest quotation and the median and weighted average of public funds, social security funds, pensions, enterprise annuity funds and insurance funds after excluding the highest quotation, the relevant subsidiaries of the sponsor will participate in the strategic placement of the issue in accordance with relevant regulations) The number of shares issued was 1686050, accounting for 5.00% of the number of shares issued this time. The difference between the final placement number and the initial placement number of strategic investors was transferred back to offline issuance.
Before the launch of the call back mechanism, the initial offline issuance of this issuance was 22424950 shares, accounting for about 70.00% of the issuance after deducting the initial strategic placement; The initial number of shares issued online was 9.61 million, accounting for about 30.00% of the number issued after deducting the initial strategic placement.
The total quantity of final offline and online issuance is the total quantity of this issuance minus the final strategic placement quantity. The final offline and online issuance quantity will be determined according to the call back situation. The final offline and online issuance quantity and strategic placement (if any) will be specified in the announcement of initial public offering of shares by Shandong Sanyuan Biotechnology Co., Ltd. and preliminary placement results of offline issuance listed on GEM published on January 26, 2022 (T + 2).
In order to facilitate investors to understand the relevant situation and development prospect of the issuer and the relevant arrangements for subscription of this offering, the issuer and the sponsor (lead underwriter) of this offering will hold an online roadshow on January 21, 2022 (t-1). Please pay attention to it.
1、 Online roadshow website:
China Securities Journal · China Securities Network（ http://www.cs.com.cn./roadshow ）
2、 Online roadshow time: 14:00-17:00, January 21, 2022 (Friday, t-1)
3、 Participants: key members of the issuer’s management and relevant personnel of the sponsor (lead underwriter).
The full text of the prospectus and relevant materials of this offering can be found on five websites designated by the CSRC (cninfo.com, www.cn.info.com.cn; csi.com, www.cs.com.cn; China securities.com, www.cn.stock.com; securities times, www.stcn.com; and Securities Daily, www.zqrb.cn) Consult.
Please pay attention to it.
Issuer: sponsor (lead underwriter) of Shandong Sanyuan Biotechnology Co., Ltd.: China Securities Co.Ltd(601066) January 20, 2022 (there is no text on this page, which is the cover page of online roadshow announcement of Shandong Sanyuan Biotechnology Co., Ltd. on initial public offering and listing on GEM)
Issuer: Shandong Sanyuan Biotechnology Co., Ltd. (this page has no text and is the seal page of the online roadshow announcement of Shandong Sanyuan Biotechnology Co., Ltd. on initial public offering and listing on the GEM)
Sponsor (lead underwriter): China Securities Co.Ltd(601066) mm / DD / yy
